Two Sigma Advisers LP Has $2.27 Million Stake in Oscar Health, Inc. (NYSE:OSCR)

Two Sigma Advisers LP lowered its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 85.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 168,700 shares of the company's stock after selling 1,006,400 shares during the quarter. Two Sigma Advisers LP owned 0.07% of Oscar Health worth $2,267,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of OSCR. Vanguard Group Inc. boosted its position in Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after acquiring an additional 586,626 shares during the period. Deerfield Management Company L.P. Series C lifted its holdings in shares of Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after buying an additional 3,983,325 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after buying an additional 8,051,379 shares during the last quarter. Thrive Capital Management LLC lifted its holdings in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC lifted its holdings in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after buying an additional 2,151,256 shares during the last quarter. Institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Wall Street Zen raised Oscar Health from a "hold" rating to a "buy" rating in a research note on Saturday. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $18.50.

Oscar Health Stock Performance

Shares of OSCR stock traded down $0.03 during trading on Friday, reaching $13.77. The company had a trading volume of 8,094,262 shares, compared to its average volume of 4,385,652. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm's 50 day simple moving average is $13.73 and its two-hundred day simple moving average is $14.59. The company has a market capitalization of $3.51 billion, a PE ratio of -688.16 and a beta of 1.75. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company's revenue for the quarter was up 42.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.62 EPS. Sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now directly owns 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 24.39% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.